Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Example Prior Systemic Therapy Statement — Tamoxifen Adjuvant Hormonal Therapy

Raw json | Download

{
  "resourceType" : "MedicationStatement",
  "id" : "PriorSystemicTherapyStatementExample",
  "meta" : {
    "profile" : [
      🔗 "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-prior-systemic-therapy-statement"
    ]
  },
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationStatement PriorSystemicTherapyStatementExample</b></p><a name=\"PriorSystemicTherapyStatementExample\"> </a><a name=\"hcPriorSystemicTherapyStatementExample\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-nccp-prior-systemic-therapy-statement.html\">NCCP Prior Systemic Therapy Statement</a></p></div><p><b>status</b>: Completed</p><p><b>category</b>: <span title=\"Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs HORMONAL-THERAPY}\">Hormonal Therapy</span></p><p><b>medication</b>: <span title=\"Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/generic-products-cs TAMOXIFEN}\">Tamoxifen</span></p><p><b>subject</b>: <a href=\"Patient-example-patient.html\">Mary Wanjiku  Female, DoB: 1975-06-15</a></p><p><b>effective</b>: 2018-03-01 --&gt; 2023-02-28</p><p><b>reasonReference</b>: <a href=\"Condition-example-condition.html\">Condition C50 — Malignant neoplasm of breast</a></p><p><b>note</b>: </p><blockquote><div><p>Completed 5 years of adjuvant tamoxifen. Switched to letrozole following menopause in 2021.</p>\n</div></blockquote></div>"
  },
  "status" : "completed",
  "category" : {
    "coding" : [
      {
        "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs",
        "code" : "HORMONAL-THERAPY",
        "display" : "Hormonal Therapy"
      }
    ]
  },
  "medicationCodeableConcept" : {
    "coding" : [
      {
        "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/generic-products-cs",
        "code" : "TAMOXIFEN",
        "display" : "Tamoxifen"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/example-patient"
  },
  "effectivePeriod" : {
    "start" : "2018-03-01",
    "end" : "2023-02-28"
  },
  "reasonReference" : [
    {
      🔗 "reference" : "Condition/example-condition"
    }
  ],
  "note" : [
    {
      "text" : "Completed 5 years of adjuvant tamoxifen. Switched to letrozole following menopause in 2021."
    }
  ]
}